韩国肌肉骨骼疾病的经济负担：一项横断面研究。
The economic burden of musculoskeletal disease in Korea: a cross sectional study.
机构信息
Department of Preventive Medicine, College of Medicine, Korea University, Seoul, Korea.
出版信息
BMC Musculoskelet Disord. 2011 Jul 13;12:157. doi: 10.1186/1471-2474-12-157.
BACKGROUND
Musculoskeletal diseases are becoming increasingly important due to population aging. However, studies on the economic burden of musculoskeletal disease in Korea are scarce. Therefore, we conducted a population-based study to measure the economic burden of musculoskeletal disease in Korea using nationally representative data.
METHODS
This study used a variety of data sources such as national health insurance statistics, the Korea Health Panel study and cause of death reports generated by the Korea National Statistical Office to estimate the economic burden of musculoskeletal disease. The total cost of musculoskeletal disease was estimated as the sum of direct medical care costs, direct non-medical care costs, and indirect costs. Direct medical care costs are composed of the costs paid by the insurer and patients, over the counter drugs costs, and other costs such as medical equipment costs. Direct non-medical costs are composed of transportation and caregiver costs. Indirect costs are the sum of the costs associated with premature death and the costs due to productivity loss. Age, sex, and disease specific costs were estimated.
RESULTS
Among the musculoskeletal diseases, the highest costs are associated with other dorsopathies, followed by disc disorder and arthrosis. The direct medical and direct non-medical costs of all musculoskeletal diseases were $4.18 billion and $338 million in 2008, respectively. Among the indirect costs, those due to productivity loss were $2.28 billion and costs due to premature death were $79 million. The proportions of the total costs incurred by male and female patients were 33.8% and 66.2%, respectively, and the cost due to the female adult aged 20-64 years old was highest. The total economic cost of musculoskeletal disease was $6.89 billion, which represents 0.7% of the Korean gross domestic product.
CONCLUSIONS
The economic burden of musculoskeletal disease in Korea is substantial. As the Korean population continues to age, the economic burden of musculoskeletal disease will continue to increase. Policy measures aimed at controlling the cost of musculoskeletal disease are therefore required.
背景
由于人口老龄化，肌肉骨骼疾病变得越来越重要。然而，关于韩国肌肉骨骼疾病经济负担的研究很少。因此，我们进行了一项基于人群的研究，使用全国代表性数据来衡量韩国肌肉骨骼疾病的经济负担。
方法
本研究使用了各种数据源，如国家健康保险统计数据、韩国健康面板研究和韩国国家统计局的死因报告，以估计肌肉骨骼疾病的经济负担。肌肉骨骼疾病的总费用估计为直接医疗费用、直接非医疗费用和间接费用的总和。直接医疗费用由保险公司和患者支付的费用、非处方药物费用和医疗设备费用等其他费用组成。直接非医疗费用由交通和护理人员费用组成。间接费用是与过早死亡相关的费用和因生产力损失而产生的费用之和。按年龄、性别和疾病特异性成本进行了估计。
结果
在肌肉骨骼疾病中，其他背疼疾病的费用最高，其次是椎间盘疾病和关节炎。2008 年，所有肌肉骨骼疾病的直接医疗和直接非医疗费用分别为 41.8 亿美元和 3.38 亿美元。在间接费用中，因生产力损失而产生的费用为 22.8 亿美元，因过早死亡而产生的费用为 7900 万美元。男女患者的总费用比例分别为 33.8%和 66.2%，20-64 岁成年女性的费用最高。肌肉骨骼疾病的总经济成本为 68.9 亿美元，占韩国国内生产总值的 0.7%。
结论
韩国肌肉骨骼疾病的经济负担相当大。随着韩国人口的老龄化，肌肉骨骼疾病的经济负担将继续增加。因此，需要采取控制肌肉骨骼疾病成本的政策措施。
Zotero 插件